Delivery Order SPE2DB22D3301-SPE2DB25FZ0YU
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,244 vials of 110 mg Artesunate. The award has a ceiling value of $33,451.08 and a period of performance extending through May 15, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, has a potential value of one hundred five thousand six hundred eighty-five dollars and seventy-six cents ($105,685.76) to supply four hundred fifty-six thousand two hundred forty-eight thousand nine hundred ninety-four (4562489499) units of artesunate, a medication used to treat malaria, in one hundred ten (110) milligram vials. The contract has a firm fixed price and period of performance through...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,606.72 to AmerisourceBergen Drug Corp for COARTEM 20-120MG 24S, an antimalarial medication. The contract is a firm fixed price, non-competitive delivery order with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 10, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $10,136.00 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor agreement running through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,090 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, competitively awarded delivery order (No. 4568845252) was issued under no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $100,813.44 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, awarded on June 30, 2025, represents a non-set-aside competitive award with an ultimate completion date of July 1, 2025. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion global...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively bid delivery order valued at $98,786.59 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $227,952.81 by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $24,371.30 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,095.44 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0YUDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,715.08 on September 15, 2025, for the supply of Artesunate 110 mg vials, with an ultimate completion date of October 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical federal medical vendor, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitive procurement processes. This award for Artesunate, an antimalarial medication, reflects the company's role in supplying specialized medications to support the Defense Health Agency and other government healthcare systems' operational needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 9/15/25 |